mRNA Delivery
Nanocarriers for messenger RNA therapeutics and vaccines
Arrowhead Research
Pasadena, United States
Biopharmaceutical company developing targeted RNAi therapeutics using proprietary TRiM platform
Moderna
Cambridge, United States
Pioneer in mRNA therapeutics using lipid nanoparticle (LNP) delivery technology for vaccines and medicines
BioNTech
Mainz, Germany
Immunotherapy company leveraging lipid nanoparticle delivery for mRNA vaccines and cancer therapies
Acuitas Therapeutics
Vancouver, Canada
Leading developer of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, partner for COVID-19 vaccines
Precision NanoSystems
Vancouver, Canada
Provider of instruments for scalable nanoparticle manufacturing for gene therapies and mRNA vaccines
Alnylam Pharmaceuticals
Cambridge, United States
Pioneer in RNAi therapeutics using lipid nanoparticle delivery for treatment of genetic diseases
Intellia Therapeutics
Cambridge, United States
Gene editing company using lipid nanoparticle delivery for in vivo CRISPR therapeutics
NanoVation Therapeutics
Vancouver, Canada
Developer of next-generation lipid nanoparticle delivery systems for RNA therapeutics
Verve Therapeutics
Boston, United States
Gene editing company using lipid nanoparticle delivery for cardiovascular disease treatment
Sirnaomics
Gaithersburg, United States
Clinical-stage biopharmaceutical company developing RNAi therapeutics using polypeptide nanoparticle delivery
CureVac
Tubingen, Germany
Pioneer in mRNA technology using lipid nanoparticle delivery for vaccines and therapeutics
Genevant Sciences
Cambridge, United States
Developer of lipid nanoparticle and ligand conjugate delivery systems for genetic medicines
Arcturus Therapeutics
San Diego, United States
Developer of LUNAR lipid nanoparticle delivery platform for mRNA medicines
Silence Therapeutics
London, United Kingdom
Pioneer in precision RNAi medicines using mRNAi GOLD platform with GalNAc delivery
Dicerna Pharmaceuticals
Lexington, United States
Developer of GalXC RNAi platform for targeted gene silencing therapeutics
Arrowhead Pharmaceuticals
Pasadena, United States
Leader in RNAi therapeutics using targeted delivery
Translate Bio
Lexington, United States
mRNA therapeutics company with proprietary LNP technology, acquired by Sanofi
Etherna Immunotherapies
Niel, Belgium
mRNA immunotherapy company with proprietary LNP delivery technology
eTheRNA Immunotherapies
Niel, Belgium
mRNA immunotherapy with proprietary delivery platform
Strand Therapeutics
Boston, United States
Programmable mRNA therapeutics with logic gates
Nutcracker Therapeutics
Emeryville, United States
Automated mRNA manufacturing with microfluidic systems
Mina Therapeutics
London, United Kingdom
Small activating RNA therapeutics with LNP delivery
Tidal Therapeutics
Cambridge, United States
LNP-based in vivo gene therapy for immune cells, acquired by Sanofi
ReNAgade Therapeutics
Cambridge, United States
RNA delivery technology for extrahepatic targets
NanoTherapeutics
Alachua, United States
Biopharmaceutical nanotechnology development
LNP Japan
Tokyo, Japan
Lipid nanoparticle manufacturing services for RNA therapeutics
Nanobio2Pharma
Bordeaux, France
Nanoparticle drug formulation and CDMO services
Ethris GmbH
Planegg, Germany
SNIM RNA stabilized mRNA therapeutics
Entos Pharmaceuticals
Edmonton, Canada
Fusogenix nucleic acid delivery platform
Arrowhead Pharmaceuticals
Pasadena, United States
TRiM RNAi therapeutics platform
Nitto Denko Avecia
Milford, United States
Oligonucleotide and nucleic acid CDMO services
Sixfold Bioscience
London, United Kingdom
AI-driven nanoparticle delivery optimization
Lonza
Basel, Switzerland
Life sciences and specialty ingredients
CR Micro
Wuxi, China
Power semiconductor foundry
Alnylam Pharmaceuticals
Cambridge, United States
Leader in RNAi therapeutics using lipid nanoparticle delivery for genetic diseases
Arbutus Biopharma
Vancouver, Canada
Develops lipid nanoparticle technology for hepatitis B and other infectious diseases
Arcturus Therapeutics
San Diego, United States
RNA medicines company using LUNAR lipid nanoparticle delivery platform
Acuitas Therapeutics
Vancouver, Canada
Develops lipid nanoparticle delivery systems for nucleic acid therapeutics
Genevant Sciences
Cambridge, United States
Lipid nanoparticle and ligand conjugate delivery platforms for genetic medicines
Verve Therapeutics
Cambridge, United States
Gene editing company for cardiovascular disease using base editing and LNP delivery
Arrowhead Pharmaceuticals
Pasadena, United States
RNAi therapeutics company developing targeted delivery systems for genetic medicines
Dicerna Pharmaceuticals
Lexington, United States
RNAi therapeutics using GalXC delivery platform for liver-targeted gene silencing
Afrigen Biologics
Cape Town, South Africa
African mRNA vaccine hub developing lipid nanoparticle delivery technology
Catalent
Somerset, United States
Contract manufacturer with lipid nanoparticle and advanced drug delivery capabilities
Lonza Pharma
Basel, Switzerland
Life sciences company with lipid nanoparticle manufacturing for mRNA therapeutics
Evonik Health Care
Essen, Germany
Specialty chemicals for pharmaceutical drug delivery including lipid nanoparticles
Croda Health Care
Snaith, United Kingdom
Specialty ingredients including lipids for nanoparticle drug delivery
Piramal Pharma Solutions
Mumbai, India
CDMO with capabilities in lipid nanoparticle and advanced drug delivery systems
Siegfried Holding
Zofingen, Switzerland
Pharmaceutical CDMO with particle engineering and formulation capabilities
Corden Pharma
Basel, Switzerland
CDMO specializing in lipids and lipid nanoparticle manufacturing
Exelead
Indianapolis, United States
CDMO focused on liposomes and lipid nanoparticle drug delivery systems
T&T Scientific
Knoxville, United States
Liposome and lipid nanoparticle preparation equipment and services
Northern Lipids
Vancouver, Canada
CDMO for liposomal and lipid nanoparticle drug delivery formulations
Avanti Polar Lipids
Alabaster, United States
High-purity lipids and liposomes for research and drug delivery applications
NOF Corporation
Tokyo, Japan
PEG-lipid conjugates and functional lipids for liposome drug delivery
Merck Life Science
Darmstadt, Germany
Life science products including lipids and nanomaterials for drug delivery research
Evonik Health Care
Essen, Germany
Drug delivery polymers and lipid nanoparticle components
Alnylam Pharmaceuticals
Cambridge, United States
Pioneer in RNAi therapeutics with lipid nanoparticle delivery
Stoke Therapeutics
Bedford, United States
Antisense oligonucleotides to upregulate protein expression
Dicerna Pharmaceuticals
Lexington, United States
RNAi therapeutics using GalNAc delivery (acquired by Novo Nordisk)
Croda International
Snaith, United Kingdom
Specialty chemicals with Avanti lipids for LNP formulations
Entos Pharmaceuticals
Edmonton, Canada
Fusogenix DNA delivery platform for gene therapy
Kernal Biologics
Cambridge, United States
Self-amplifying mRNA with immune-silent delivery
Replicate Bioscience
San Diego, United States
Self-replicating RNA therapeutics platform
Laronde
Cambridge, United States
Endless RNA (eRNA) technology for persistent protein expression
Orna Therapeutics
Cambridge, United States
Circular RNA platform for cell therapy and protein replacement
Lonza Cell and Gene
Basel, Switzerland
Global CDMO providing cell and gene therapy manufacturing services
SeraGene Therapeutics
London, United Kingdom
RNA and nanomedicine treatments for blood disorders
Aurora Biosynthetics
Singapore, Singapore
GMP manufacturing of plasmid DNA, mRNA and lipid nanoparticles for Asia Pacific
Mepsgen
Seoul, South Korea
NanoCalibur automated nanoparticle production using microfluidic technology
Exsilio Therapeutics
Boston, United States
mRNA platform for revocable genetic medicines
Cello Therapeutics
San Diego, United States
Cell membrane-coated nanoparticles for immunotherapy delivery with FDA IND status
ExonanoRNA
Boston, United States
RNA nanoparticles and exosomes for cancer therapeutics
Phosphorex
Hopkinton, United States
CDMO for lipid nanoparticle and liposome drug delivery
DIANT Pharma
San Diego, United States
LiFT continuous manufacturing system for lipid nanoparticles at GMP scale